HRV Pharma (Group) & New Horizon Global Pharma are proud to announce that we have been honoured at the Economic Times RE-Pharma Awards 2026 with the Excellence in Pharma Global Business Support award. This prestigious award reinforces our commitment to delivering compliant, reliable, and growth‑oriented pharmaceutical solutions across regulated global markets.
A Recognition Built on Global Execution
The award reflects HRV Pharma’s continued focus on strengthening international pharmaceutical supply chains through disciplined execution and regulatory excellence.
- Comprehensive Global API Support: Structured regulatory backing including US DMFs, EU compliance frameworks, and expanding MENA market initiatives.
- Accelerated Market Access: A responsive and agile virtual operating model enabling faster execution and streamlined entry into regulated markets.
- Audit‑Ready Reliability: Robust quality systems, strong data integrity practices, and regulatory alignment across multiple jurisdictions.
- Proven Business Impact: Successful multi‑market expansion initiatives and long‑term strategic partnerships with global stakeholders.
Strengthening Global Pharmaceutical Partnerships
At HRV Pharma, we believe sustainable growth in the pharmaceutical industry is built on transparency, compliance, and trust. This recognition validates our efforts in supporting partners with reliable sourcing, regulatory clarity, and operational excellence.
As global markets continue to evolve, we remain committed to enabling seamless cross‑border pharmaceutical collaboration while maintaining the highest standards of quality and compliance.
Looking Ahead
This achievement marks another milestone in HRV Pharma’s journey toward building resilient and future‑ready pharmaceutical supply solutions. We extend our sincere appreciation to our global partners, clients, and team members whose dedication and trust made this recognition possible.
We look forward to continuing to support pharmaceutical companies worldwide in navigating complex regulatory landscapes and expanding into new markets with confidence.
Frequently Asked Questions
Q. What is the ET RE-Pharma Award for Excellence in Global Business Support?
The ET RE-Pharma Award for Excellence in Global Business Support recognises pharmaceutical organizations that demonstrate strong regulatory execution, compliance leadership, and measurable impact across international markets.
Q. Why was HRV Pharma recognised at the ET RE-Pharma Awards 2026?
HRV Pharma was honoured for its structured global API support, regulatory strength across US and EU markets, agile virtual operating model, and proven multi-market expansion capabilities.
Q. What does Global Business Support mean in the pharmaceutical industry?
Global Business Support refers to enabling pharmaceutical partners with regulatory filings, compliance frameworks, supply-chain coordination, audit readiness, and market expansion strategies across multiple jurisdictions.
Q. How does HRV Pharma support regulated global markets?
HRV Pharma provides US DMF filings, EU compliance frameworks, structured MENA expansion strategies, quality-controlled sourcing, and unified regulatory oversight to ensure seamless cross-border pharmaceutical collaboration.
Q. What does this award mean for HRV Pharma’s partners?
This recognition reinforces HRV Pharma’s reliability, compliance discipline, and global execution capabilities—providing partners with confidence in long-term collaboration and regulatory alignment.
